Relationship between the concanavalin A-agglutinability and deformability of human erythrocytes.
Cellular deformability has been proposed in the past as a major determinant of lectin-mediated agglutination of cells. In this paper we have evaluated the correlation between deformability and Con A-agglutinability of human erythrocytes by subjecting them to agents that alter either one of the properties and evaluating the effect on the other property. The following results have been obtained: (i) Treatment with pronase or trypsin, which makes the Con A-nonagglutinable normal red cells highly agglutinable, has practically no effect on deformability; while neuraminidase treatment, with a similar effect on agglutinability, produces a small but statistically significant reduction in deformability. (ii) Diamide treatment, on the other hand, produces a drastic reduction in the deformability of pronase-treated erythrocytes but has no effect on the Con A-agglutinability of the cells. Dinitrophenol also reduces deformability but without altering the agglutinability, (iii) Chlorpromazine, at 2 x 10(-5) M, does not have any effect on the deformability of trypsinized cells, but increases the agglutinability substantially. When the Con A-agglutinability of the cells and their deformability after these treatments are compared, a correlation coefficient r = -0.353 (P greater than 0.1) is obtained. This indicates the lack of any direct correlation between the two parameters, and rules out any significant role of deformability in the determination of Con A-agglutinability of erythrocytes. The agglutination with the lectin is completely reversed by methyl alpha-D-mannoside, the specific inhibitory sugar for Con A, also ruling out any secondary role for deformability in the non-lectin-mediated stabilization of clumps. Upon incubation of normal erythrocytes with Con A. a dose-dependent decrease in deformability is observed, with the deformability index falling to almost 25% of the normal value with 500 microgram/ml Con A. This indicates that Con A binding to its receptor produces changes in the membrane probably by altering properties of the membrane skeleton.
Pestonjamasp
K N
KN
Biological Chemistry Division, Tata Memorial Centre, Parel, Bombay, India.
Mehta
N G
NG
D002746:Chlorpromazine / Q000494:pharmacology; D003208:Concanavalin A / Q000494:pharmacology*; D003958:Diamide / Q000494:pharmacology; D004140:Dinitrophenols / Q000494:pharmacology; D004907:Erythrocyte Deformability / Q000187:drug effects; D006384:Hemagglutination / Q000187:drug effects; D006801:Humans; D009439:Neuraminidase / Q000494:pharmacology; D011402:Pronase / Q000494:pharmacology; D014357:Trypsin / Q000494:pharmacology
D004140:Dinitrophenols; D003958:Diamide; D003208:Concanavalin A; D009439:Neuraminidase; D014357:Trypsin; D011402:Pronase; D002746:Chlorpromazine